You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The test relies on a spermine risk score coupled with a urine test to predict which patients are most likely to have prostate cancer.
The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
NASA increasingly believes the platform could be used in the medical arena.
SureScreen's test will be deployed in educational settings, as well as for the testing of National Health Service and care home staff.
Based on the results of the new studies, the Norwegian company is positioning its calprotectin test as an alternative to conventional ELISAs.
MeMed believes its tests can be used to identify which COVID-19 patients require more aggressive treatment with corticosteroids.
The organization intends to deploy a prototype of the platform in Brussels Airport next summer.
The PCR test is the first offering from the firm, formerly known as Concepta, since it acquired Manchester-based startup The Genome Store in November.
Called the COVID Bubble Test, the UK-based service allows the testing of up to 10 people on a single cartridge for £100, or £10 per person.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.